Hello from the Common Health Coalition! The 2-4-2 Digest is a weekly snapshot for health leaders - 4 key insights in 2 minutes or with 2 swipes on your phone.

Weekly Health Insights

ACIP Recap: Following ACIP’s vote to end the universal hepatitis B birth dose recommendation, insurers and federal officials say coverage will remain unchanged through 2026. Though the ACIP recommendations diverge from the evidence-supported recommendation, clinicians, hospitals and states can continue with existing practices for vaccination without any new administrative restrictions, including payment and coverage. Check out the Common Health Coalition’s December ACIP explainer here.

GLP-1 Coverage: States are reassessing whether to cover GLP-1 weight-loss medications in Medicaid as program spending rises sharply, with some states reporting increases of more than $100 million in a single year. Even with the new federal offer of $245 per month, it is unclear whether long-term savings will offset near-term budget pressures.

HHS AI Strategy: Last Thursday, HHS released its first department-wide AI strategy. The plan’s “OneHHS” model prioritizes governance, workforce training, and modernization of public health data systems and positions AI as core infrastructure for future public health delivery.

Cervical Cancer Screening: The American Cancer Society now considers self-collected HPV samples an acceptable option for cervical cancer screening, noting their potential to improve access for people who face barriers to clinician-collected exams. In May, the FDA approved the first at-home screening tool to detect cervical cancer.

Colleague Corner

A recent Public Health on Call episode explores the two-year HIV outbreak in Bangor, Maine, showing how a variety of factors - including the closure of a syringe services program, the breakup of a large encampment, and limited case-management capacity - made the outbreak harder to contain among people who use drugs and are experiencing homelessness.

“Disbanding the encampment didn’t spark the outbreak, but it did make it harder for folks to access resources… and syringe services programs were shut down just as cases were emerging. Prevention is always the best medicine… but all those really basic but crucial public health interventions are what health departments across the country are trying to do with really, really meager resources.”

– Aneri Pattani, Senior Correspondent, KFF Health News

Data Watch

A cohort study of 1,003,526 adults in Houston found that people living in communities with the highest Climate Vulnerability Index (CVI) had nearly double the incidence of type 2 diabetes compared with those in the lowest-CVI areas (2.66 vs. 1.48 cases per 100 person-years). After adjustment for demographics and clinical risk factors, high-CVI residence was associated with a 23% higher risk of developing diabetes.

Figure 1. Cumulative Diabetes Incidence by Climate Vulnerability Index (CVI) Quartile

If you find the digest useful, please share it and

encourage colleagues to consider joining the Coalition.